After a radical prostatectomy, your PSA should drop to virtually undetectable levels, typically below 0.01 ng/mL. A PSA reading that reaches 0.2 ng/mL or higher, confirmed on a second test, is the standard threshold for biochemical recurrence, meaning cancer may have returned. But how dangerous that number is depends heavily on how fast your PSA is rising and when it appears.
What Your PSA Should Be After Surgery
The prostate gland is the sole significant source of PSA in the body. Once it’s removed, PSA levels should fall to nearly zero within a few weeks. Modern ultra-sensitive tests can detect PSA as low as 0.003 ng/mL, and most men with a successful surgery will have readings below 0.01 ng/mL.
Tiny, persistent readings in the range of 0.01 to 0.02 ng/mL can be normal. These may reflect assay noise (the test’s margin of error) or trace amounts of benign prostate tissue left behind at the surgical margins, usually a small area near the apex. This leftover tissue is often devitalized by the surgery itself and produces negligible PSA. Studies show that the presence of benign tissue at the margins does not significantly predict PSA recurrence.
Once PSA reaches 0.03 ng/mL or above, the picture changes. In one study, nearly 98% of patients who hit that threshold eventually progressed to a conventional biochemical recurrence. By contrast, only about half of patients with a reading of 0.01 ng/mL ever progressed.
The 0.2 ng/mL Recurrence Threshold
The American Urological Association defines biochemical recurrence as a PSA of 0.2 ng/mL or higher, confirmed by a second reading above 0.2 ng/mL. This is the number your urologist is watching for during follow-up visits. It doesn’t mean cancer has spread or that you’ll develop symptoms. It means there are cells somewhere producing PSA, and further evaluation is needed.
In one large retrospective series, 96% of men who had an initial detectable PSA after surgery eventually saw their PSA rise above 0.2 ng/mL, typically within about 7 months. Of those, 41% went on to reach 0.4 ng/mL, and 8% eventually developed metastases. So while 0.2 ng/mL triggers action, it’s far from a death sentence. Most men at this level still have localized, treatable disease.
Why the Speed of the Rise Matters More
A single PSA number tells you less than the trend. Doctors track something called PSA doubling time: how long it takes for your PSA to double. This is one of the strongest predictors of whether a recurrence will remain local or spread to distant sites.
A PSA doubling time under 7.5 months is an independent risk factor for distant metastasis. The shorter the doubling time, the more aggressive the recurrence. In a major study of men with biochemical recurrence after prostatectomy, the risk breakdown looked like this:
- Doubling time under 3 months: More than five times the risk of metastasis compared to men with slower-rising PSA
- Doubling time 3 to 4.5 months: About four times the risk
- Doubling time 4.5 to 6 months: About three times the risk
- Doubling time over 10 months: Substantially lower risk, and many of these men do well for years
The majority of patients with a doubling time under 6 months eventually developed visible metastases on imaging. A PSA of 0.4 ng/mL that took two years to get there is a very different situation from a PSA of 0.4 ng/mL that appeared three months after an undetectable reading.
When Treatment Gets Triggered
If your PSA is rising after surgery, the most common next step is salvage radiation therapy directed at the area where the prostate used to sit. Timing matters enormously here. The AUA recommends that salvage radiation be given when PSA is at or below 0.5 ng/mL, because outcomes are significantly better at lower levels. For men at high risk of progression, radiation may even be offered when PSA is still below 0.2 ng/mL.
The data illustrate why earlier is better. Men who received salvage radiation when their PSA was between 0.03 and 0.2 ng/mL had a 66% chance of remaining recurrence-free at 10 years. Those who waited until PSA was between 0.2 and 0.5 ng/mL saw that drop to 43%. Every fraction of a nanogram counts when it comes to the effectiveness of salvage treatment.
What Imaging Can and Can’t Show
One frustrating aspect of a rising PSA after surgery is that standard imaging often can’t find the source at very low levels. PSMA PET scans, the most sensitive imaging tool currently available, have an optimal detection threshold of about 1.24 ng/mL for post-prostatectomy patients. Below that level, only about 52% of scans identify a visible lesion. Above 1.24 ng/mL, the detection rate jumps to 87%.
This creates a clinical tension. You ideally want to treat before PSA climbs too high, but you may not be able to see exactly where the recurrence is located at very low PSA levels. Your care team balances these factors when deciding whether to treat the surgical bed with radiation based on probability or wait for imaging confirmation at a slightly higher PSA.
How Often PSA Gets Checked
National Comprehensive Cancer Network guidelines recommend PSA testing every 6 to 12 months for the first five years after prostatectomy, then annually after that. Most recurrences show up within the first few years, but late recurrences are possible, which is why lifelong monitoring is standard.
If your PSA begins to rise, your doctor will likely increase testing frequency to track doubling time more accurately. Two or three readings spaced a few months apart can reveal whether the trend is slow and stable or rapidly accelerating, and that trajectory shapes every treatment decision that follows.